WellBiotec Co

WellBiotec Co FCF Conversion

Delisted

The FCF Conversion Rate (FCF/EBITDA) of WellBiotec Co (010600.KS) as of Oct 19, 2026 is 29.06 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 8.09 % — a change of 259.24% (higher).

FCF Conversion

29.06 %

YoY

259.24%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of WellBiotec Co is 2024 29.06 % . FCF Conversion Rate (FCF/EBITDA) of WellBiotec Co was 2023 8.09 % . It decreases by 259.24% higher compared to the previous year.

The WellBiotec Co FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2017
99.43 KRW
Jan 1, 2018
69.24 KRW
Jan 1, 2019
90.38 KRW
Jan 1, 2020
10.35 KRW
Jan 1, 2021
61.65 KRW
Jan 1, 2022
-7.05 KRW
Jan 1, 2023
8.09 KRW
Jan 1, 2024
29.06 KRW
The WellBiotec Co FCF Conversion history
YEARFCF ConversionYoY
29.06 %+259.24%
8.09 %-214.79%
-7.05 %-111.43%
61.65 %+495.46%
10.35 %-88.55%
90.38 %+30.54%
69.24 %-30.36%
99.43 %-44.52%
179.22 %-70.94%
616.73 %+276.99%
163.59 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

WellBiotec Co Stock analysis

What does WellBiotec Co do? WellBiotec Co Ltd, listed on the Korea Exchange with ticker 010600.KS, is headquartered in Seoul, South Korea. The company operates in the Consumer Discretionary sector within the Textiles, Apparel & Luxury Goods industry. WellBiotec employs 29 people and had an IPO on July 18, 1997. It manufactures and sells leather products including nappa, soft, and other leathers for handbags; waterproof, Gore-Tex, and nubuck leathers for shoes; and chrome and non-chrome leathers for automotive interiors. The company supplies leather to brands such as Coach, Tumi, and Timberland. WellBiotec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about WellBiotec Co stock

FCF Conversion Rate (FCF/EBITDA) of WellBiotec Co is 29.06 % in 2024.

FCF Conversion Rate (FCF/EBITDA) of WellBiotec Co changed from 8.09 % to 29.06 %, representing a 259.24% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) WellBiotec Co since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s WellBiotec Co with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — WellBiotec Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — WellBiotec Co